We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-4 of 4

U.S. FDA contemplates new rules for internet-delivered health information
  • Gowling WLG
  • USA
  • December 3 2009

In recognition of the increasing use of the Internet by consumers for health-related information, the FDA is seeking to determine whether it needs to regulate the promotion of drugs and medical devices on the Internet.

Protection of biologics in the US
  • Gowling WLG
  • USA
  • July 27 2009

By a vote of 16 to 7, the U.S. Senate health committee approved a minimum period of 12 years before generic versions of biotech drugs can be approved.

Melissa A. Binns
  • Gowling WLG